1. Home
  2. TDW vs ELVN Comparison

TDW vs ELVN Comparison

Compare TDW & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tidewater Inc.

TDW

Tidewater Inc.

N/A

Current Price

$92.49

Market Cap

3.6B

ML Signal

N/A

Logo Enliven Therapeutics Inc.

ELVN

Enliven Therapeutics Inc.

N/A

Current Price

$54.32

Market Cap

4.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TDW
ELVN
Founded
1956
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
4.2B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
TDW
ELVN
Price
$92.49
$54.32
Analyst Decision
Hold
Strong Buy
Analyst Count
4
5
Target Price
$81.33
$43.40
AVG Volume (30 Days)
551.7K
783.2K
Earning Date
05-04-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
95.29
3.17
EPS
0.56
N/A
Revenue
N/A
N/A
Revenue This Year
$8.44
N/A
Revenue Next Year
$12.34
N/A
P/E Ratio
$166.20
N/A
Revenue Growth
N/A
N/A
52 Week Low
$46.65
$14.79
52 Week High
$101.58
$62.32

Technical Indicators

Market Signals
Indicator
TDW
ELVN
Relative Strength Index (RSI) 53.02 41.82
Support Level $88.42 $25.63
Resistance Level $93.13 $62.16
Average True Range (ATR) 3.83 1.95
MACD -0.88 -0.59
Stochastic Oscillator 27.90 1.93

Price Performance

Historical Comparison
TDW
ELVN

About TDW Tidewater Inc.

Tidewater Inc provides marine and transportation services to the offshore energy industry. The company's vessels and associated services support all phases of offshore crude oil and natural gas (also referred to as oil and gas) exploration activities, field development, production, and maintenance, as well as windfarm development and maintenance. Its services include towing and anchor handling for mobile offshore drilling units; transporting supplies and personnel necessary to sustain drilling, workovers, production activities, field abandonment, dismantlement, and restoration activities; and Others. The group manages its business through five segments, including the Americas, Asia Pacific, Middle East, Europe/Mediterranean, and West Africa.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Share on Social Networks: